Gasmotin (Mosapride Citrate)


Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus 14.0%
Reflux Oesophagitis 14.0%
Epilepsy 9.3%
Gastrointestinal Disorder 7.0%
Hypertension 7.0%
Abdominal Pain 4.7%
Dementia Alzheimer's Type 4.7%
Emphysema 4.7%
Gastritis 4.7%
Hyperprolactinaemia 4.7%
Schizophrenia 4.7%
Stomach Discomfort 4.7%
Cerebral Infarction 2.3%
Dyspepsia 2.3%
Hepatic Function Abnormal 2.3%
Hyperlipidaemia 2.3%
Lung Squamous Cell Carcinoma Stage Unspecified 2.3%
Oral Pain 2.3%
Pain 2.3%
Oculomucocutaneous Syndrome 13.3%
Prothrombin Time Prolonged 13.3%
Reflux Oesophagitis 13.3%
Acute Myocardial Infarction 6.7%
Blood Alkaline Phosphatase Increased 6.7%
Meniere's Disease 6.7%
Pemphigoid 6.7%
Rash 6.7%
Rhabdomyolysis 6.7%
Skin Discolouration 6.7%
Toxic Skin Eruption 6.7%
Urine Abnormality 6.7%
Concomitant
Multiple Myeloma 13.4%
Lung Adenocarcinoma 12.6%
Parkinson's Disease 7.8%
Lupus Nephritis 7.4%
Major Depression 6.9%
Drug Use For Unknown Indication 5.6%
Cerebral Infarction 4.8%
Hypertonic Bladder 4.8%
Dementia Alzheimer's Type 4.3%
Rheumatoid Arthritis 4.3%
Hyperphosphataemia 3.9%
Oedema Peripheral 3.5%
Back Pain 3.0%
Depression 3.0%
Non-small Cell Lung Cancer 3.0%
Convulsion Neonatal 2.6%
Prophylactic Chemotherapy 2.6%
Diabetes Mellitus Non-insulin-dependent 2.2%
Epilepsy 2.2%
Generalised Oedema 2.2%
Vomiting 18.6%
White Blood Cell Count Decreased 9.3%
Platelet Count Decreased 5.8%
Pyrexia 5.8%
Rash 5.8%
Interstitial Lung Disease 4.7%
Restlessness 4.7%
Therapy Non-responder 4.7%
Condition Aggravated 3.5%
Hypotension 3.5%
Large Intestinal Ulcer Haemorrhage 3.5%
Liver Disorder 3.5%
Oedema Peripheral 3.5%
Productive Cough 3.5%
Septic Shock 3.5%
Spinal Cord Haemorrhage 3.5%
Tremor 3.5%
Tumour Lysis Syndrome 3.5%
Ventricular Flutter 3.5%
Aplasia Pure Red Cell 2.3%

Drug Data